Skip to main content
Menu
Main navigation
News
News sub-navigation
All news
Seminars
Presentation
Presentation sub-navigation
CREATIS
Organigram
People directory
Staff
Contacts
Access
Research
Research sub-navigation
Research teams
Transversal projects
Structuring projects
Imaging platform
Activity reports
Data information note
Contributions
Contributions sub-navigation
Publications
Patents
Software
Studies & Training
Studies & Training sub-navigation
Implications dans les formations
Doctoral Studies
Jobs Opportunities
French
English
Search
Search
Search
Search
Search
Search API form
Search
User account menu
Account
Log in
Breadcrumb
Accueil
A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.
A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.
Barre liens pratiques
Authentication
Intranet
Rss feed
Creatis on Twitter
Webmail
French
English